Molecular Profiles of Parvalbumin-Immunoreactive Neurons in the Superior Temporal Cortex in Schizophrenia
Abstract Dysregulation of pyramidal cell network function by the soma- and axon-targeting inhibitory neurons that contain the calcium-binding protein parvalbumin (PV) represents a core pathophysiological feature of schizophrenia. In order to gain insight into the molecular basis of their functional...
Saved in:
Published in | Journal of neurogenetics Vol. 28; no. 1-2; pp. 70 - 85 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Informa Healthcare
01.06.2014
Taylor & Francis |
Subjects | |
Online Access | Get full text |
ISSN | 0167-7063 1563-5260 1026-8057 1563-5260 |
DOI | 10.3109/01677063.2013.878339 |
Cover
Abstract | Abstract
Dysregulation of pyramidal cell network function by the soma- and axon-targeting inhibitory neurons that contain the calcium-binding protein parvalbumin (PV) represents a core pathophysiological feature of schizophrenia. In order to gain insight into the molecular basis of their functional impairment, we used laser capture microdissection (LCM) to isolate PV-immunolabeled neurons from layer 3 of Brodmann's area 42 of the superior temporal gyrus (STG) from postmortem schizophrenia and normal control brains. We then extracted ribonucleic acid (RNA) from these neurons and determined their messenger RNA (mRNA) expression profile using the Affymetrix platform of microarray technology. Seven hundred thirty-nine mRNA transcripts were found to be differentially expressed in PV neurons in subjects with schizophrenia, including genes associated with WNT (wingless-type), NOTCH, and PGE2 (prostaglandin E2) signaling, in addition to genes that regulate cell cycle and apoptosis. Of these 739 genes, only 89 (12%) were also differentially expressed in pyramidal neurons, as described in the accompanying paper, suggesting that the molecular pathophysiology of schizophrenia appears to be predominantly neuronal type specific. In addition, we identified 15 microRNAs (miRNAs) that were differentially expressed in schizophrenia; enrichment analysis of the predicted targets of these miRNAs included the signaling pathways found by microarray to be dysregulated in schizophrenia. Taken together, findings of this study provide a neurobiological framework within which hypotheses of the molecular mechanisms that underlie the dysfunction of PV neurons in schizophrenia can be generated and experimentally explored and, as such, may ultimately inform the conceptualization of rational targeted molecular intervention for this debilitating disorder. |
---|---|
AbstractList | Dysregulation of pyramidal cell network function by the soma- and axon-targeting inhibitory neurons that contain the calcium-binding protein parvalbumin (PV) represents a core pathophysiological feature of schizophrenia. In order to gain insight into the molecular basis of their functional impairment, we used laser capture microdissection (LCM) to isolate PV-immunolabeled neurons from layer 3 of Brodmann's area 42 of the superior temporal gyrus (STG) from postmortem schizophrenia and normal control brains. We then extracted ribonucleic acid (RNA) from these neurons and determined their messenger RNA (mRNA) expression profile using the Affymetrix platform of microarray technology. Seven hundred thirty-nine mRNA transcripts were found to be differentially expressed in PV neurons in subjects with schizophrenia, including genes associated with WNT (wingless-type), NOTCH, and PGE2 (prostaglandin E2) signaling, in addition to genes that regulate cell cycle and apoptosis. Of these 739 genes, only 89 (12%) were also differentially expressed in pyramidal neurons, as described in the accompanying paper, suggesting that the molecular pathophysiology of schizophrenia appears to be predominantly neuronal type specific. In addition, we identified 15 microRNAs (miRNAs) that were differentially expressed in schizophrenia; enrichment analysis of the predicted targets of these miRNAs included the signaling pathways found by microarray to be dysregulated in schizophrenia. Taken together, findings of this study provide a neurobiological framework within which hypotheses of the molecular mechanisms that underlie the dysfunction of PV neurons in schizophrenia can be generated and experimentally explored and, as such, may ultimately inform the conceptualization of rational targeted molecular intervention for this debilitating disorder. Dysregulation of pyramidal cell network function by the soma- and axon-targeting inhibitory neurons that contain the calcium-binding protein parvalbumin (PV) represents a core pathophysiological feature of schizophrenia. In order to gain insight into the molecular basis of their functional impairment, we used laser capture microdissection (LCM) to isolate PV-immunolabeled neurons from layer 3 of Brodmann's area 42 of the superior temporal gyrus (STG) from postmortem schizophrenia and normal control brains. We then extracted ribonucleic acid (RNA) from these neurons and determined their messenger RNA (mRNA) expression profile using the Affymetrix platform of microarray technology. Seven hundred thirty-nine mRNA transcripts were found to be differentially expressed in PV neurons in subjects with schizophrenia, including genes associated with WNT (wingless-type), NOTCH, and PGE2 (prostaglandin E2) signaling, in addition to genes that regulate cell cycle and apoptosis. Of these 739 genes, only 89 (12%) were also differentially expressed in pyramidal neurons, as described in the accompanying paper, suggesting that the molecular pathophysiology of schizophrenia appears to be predominantly neuronal type specific. In addition, we identified 15 microRNAs (miRNAs) that were differentially expressed in schizophrenia; enrichment analysis of the predicted targets of these miRNAs included the signaling pathways found by microarray to be dysregulated in schizophrenia. Taken together, findings of this study provide a neurobiological framework within which hypotheses of the molecular mechanisms that underlie the dysfunction of PV neurons in schizophrenia can be generated and experimentally explored and, as such, may ultimately inform the conceptualization of rational targeted molecular intervention for this debilitating disorder.Dysregulation of pyramidal cell network function by the soma- and axon-targeting inhibitory neurons that contain the calcium-binding protein parvalbumin (PV) represents a core pathophysiological feature of schizophrenia. In order to gain insight into the molecular basis of their functional impairment, we used laser capture microdissection (LCM) to isolate PV-immunolabeled neurons from layer 3 of Brodmann's area 42 of the superior temporal gyrus (STG) from postmortem schizophrenia and normal control brains. We then extracted ribonucleic acid (RNA) from these neurons and determined their messenger RNA (mRNA) expression profile using the Affymetrix platform of microarray technology. Seven hundred thirty-nine mRNA transcripts were found to be differentially expressed in PV neurons in subjects with schizophrenia, including genes associated with WNT (wingless-type), NOTCH, and PGE2 (prostaglandin E2) signaling, in addition to genes that regulate cell cycle and apoptosis. Of these 739 genes, only 89 (12%) were also differentially expressed in pyramidal neurons, as described in the accompanying paper, suggesting that the molecular pathophysiology of schizophrenia appears to be predominantly neuronal type specific. In addition, we identified 15 microRNAs (miRNAs) that were differentially expressed in schizophrenia; enrichment analysis of the predicted targets of these miRNAs included the signaling pathways found by microarray to be dysregulated in schizophrenia. Taken together, findings of this study provide a neurobiological framework within which hypotheses of the molecular mechanisms that underlie the dysfunction of PV neurons in schizophrenia can be generated and experimentally explored and, as such, may ultimately inform the conceptualization of rational targeted molecular intervention for this debilitating disorder. Dysregulation of pyramidal cell network function by the soma- and axon-targeting inhibitory neurons that contain the calcium-binding protein parvalbumin (PV) represents a core pathophysiological feature of schizophrenia. In order to gain insight into the molecular basis of their functional impairment, we used laser capture microdissection (LCM) to isolate PV-immunolabeled neurons from layer 3 of Brodmann's area 42 of the superior temporal gyrus (STG) from postmortem schizophrenia and normal control brains. We then extracted ribonucleic acid (RNA) from these neurons and determined their messenger RNA (mRNA) expression profile using the Affymetrix platform of microarray technology. Seven hundred thirty-nine mRNA transcripts were found to be differentially expressed in PV neurons in subjects with schizophrenia, including genes associated with WNT (wingless-type), NOTCH, and PGE 2 (prostaglandin E 2 ) signaling, in addition to genes that regulate cell cycle and apoptosis. Of these 739 genes, only 89 (12%) were also differentially expressed in pyramidal neurons, as described in the accompanying paper, suggesting that the molecular pathophysiology of schizophrenia appears to be predominantly neuronal type specific. In addition, we identified 15 microRNAs (miRNAs) that were differentially expressed in schizophrenia; enrichment analysis of the predicted targets of these miRNAs included the signaling pathways found by microarray to be dysregulated in schizophrenia. Taken together, findings of this study provide a neurobiological framework within which hypotheses of the molecular mechanisms that underlie the dysfunction of PV neurons in schizophrenia can be generated and experimentally explored and, as such, may ultimately inform the conceptualization of rational targeted molecular intervention for this debilitating disorder. Abstract Dysregulation of pyramidal cell network function by the soma- and axon-targeting inhibitory neurons that contain the calcium-binding protein parvalbumin (PV) represents a core pathophysiological feature of schizophrenia. In order to gain insight into the molecular basis of their functional impairment, we used laser capture microdissection (LCM) to isolate PV-immunolabeled neurons from layer 3 of Brodmann's area 42 of the superior temporal gyrus (STG) from postmortem schizophrenia and normal control brains. We then extracted ribonucleic acid (RNA) from these neurons and determined their messenger RNA (mRNA) expression profile using the Affymetrix platform of microarray technology. Seven hundred thirty-nine mRNA transcripts were found to be differentially expressed in PV neurons in subjects with schizophrenia, including genes associated with WNT (wingless-type), NOTCH, and PGE2 (prostaglandin E2) signaling, in addition to genes that regulate cell cycle and apoptosis. Of these 739 genes, only 89 (12%) were also differentially expressed in pyramidal neurons, as described in the accompanying paper, suggesting that the molecular pathophysiology of schizophrenia appears to be predominantly neuronal type specific. In addition, we identified 15 microRNAs (miRNAs) that were differentially expressed in schizophrenia; enrichment analysis of the predicted targets of these miRNAs included the signaling pathways found by microarray to be dysregulated in schizophrenia. Taken together, findings of this study provide a neurobiological framework within which hypotheses of the molecular mechanisms that underlie the dysfunction of PV neurons in schizophrenia can be generated and experimentally explored and, as such, may ultimately inform the conceptualization of rational targeted molecular intervention for this debilitating disorder. |
Author | Mauney, Sarah A. Woo, Tsung-Ung W. Pietersen, Charmaine Y. Seidman, Larry J. Kim, Susie S. Mccarley, Robert W. Passeri, Eleonora Goldstein, Jill M. Petreyshen, Tracey L. Shenton, Martha E. Lim, Maribel P. Sonntag, Kai-C. Rooney, Robert J. |
AuthorAffiliation | 6 Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA 5 Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA 1 Laboratory of Cellular Neuropathology, McLean Hospital, Belmont, Massachusetts, USA 3 Genome Explorations Inc., Memphis, Tennessee, USA 7 Department of Psychiatry, Veterans Affairs Boston Healthcare System, Brockton, Massachusetts, USA 4 Department of Psychiatry, Brigham and Women’s Hospital, Boston, Massachusetts, USA 8 Department of Psychiatry, McLean Hospital, Belmont, Massachusetts, USA 2 Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA |
AuthorAffiliation_xml | – name: 3 Genome Explorations Inc., Memphis, Tennessee, USA – name: 5 Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA – name: 6 Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA – name: 8 Department of Psychiatry, McLean Hospital, Belmont, Massachusetts, USA – name: 7 Department of Psychiatry, Veterans Affairs Boston Healthcare System, Brockton, Massachusetts, USA – name: 1 Laboratory of Cellular Neuropathology, McLean Hospital, Belmont, Massachusetts, USA – name: 4 Department of Psychiatry, Brigham and Women’s Hospital, Boston, Massachusetts, USA – name: 2 Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA |
Author_xml | – sequence: 1 givenname: Charmaine Y. surname: Pietersen fullname: Pietersen, Charmaine Y. email: wwoo@hms.harvard.edu, wwoo@hms.harvard.edu organization: Laboratory of Cellular Neuropathology, McLean Hospital – sequence: 2 givenname: Sarah A. surname: Mauney fullname: Mauney, Sarah A. email: wwoo@hms.harvard.edu, wwoo@hms.harvard.edu organization: Laboratory of Cellular Neuropathology, McLean Hospital – sequence: 3 givenname: Susie S. surname: Kim fullname: Kim, Susie S. email: wwoo@hms.harvard.edu, wwoo@hms.harvard.edu organization: Laboratory of Cellular Neuropathology, McLean Hospital – sequence: 4 givenname: Eleonora surname: Passeri fullname: Passeri, Eleonora email: wwoo@hms.harvard.edu, wwoo@hms.harvard.edu organization: Laboratory of Cellular Neuropathology, McLean Hospital – sequence: 5 givenname: Maribel P. surname: Lim fullname: Lim, Maribel P. email: wwoo@hms.harvard.edu, wwoo@hms.harvard.edu organization: Laboratory of Cellular Neuropathology, McLean Hospital – sequence: 6 givenname: Robert J. surname: Rooney fullname: Rooney, Robert J. email: wwoo@hms.harvard.edu, wwoo@hms.harvard.edu organization: Genome Explorations Inc – sequence: 7 givenname: Jill M. surname: Goldstein fullname: Goldstein, Jill M. email: wwoo@hms.harvard.edu, wwoo@hms.harvard.edu organization: Department of Psychiatry, Brigham and Women's Hospital – sequence: 8 givenname: Tracey L. surname: Petreyshen fullname: Petreyshen, Tracey L. email: wwoo@hms.harvard.edu, wwoo@hms.harvard.edu organization: Department of Psychiatry, Massachusetts General Hospital – sequence: 9 givenname: Larry J. surname: Seidman fullname: Seidman, Larry J. email: wwoo@hms.harvard.edu, wwoo@hms.harvard.edu organization: Department of Psychiatry, Beth Israel Deaconess Medical Center – sequence: 10 givenname: Martha E. surname: Shenton fullname: Shenton, Martha E. email: wwoo@hms.harvard.edu, wwoo@hms.harvard.edu organization: Department of Psychiatry, Brigham and Women's Hospital – sequence: 11 givenname: Robert W. surname: Mccarley fullname: Mccarley, Robert W. email: wwoo@hms.harvard.edu, wwoo@hms.harvard.edu organization: Department of Psychiatry, Harvard Medical School – sequence: 12 givenname: Kai-C. surname: Sonntag fullname: Sonntag, Kai-C. email: wwoo@hms.harvard.edu, wwoo@hms.harvard.edu organization: Department of Psychiatry, Harvard Medical School – sequence: 13 givenname: Tsung-Ung W. surname: Woo fullname: Woo, Tsung-Ung W. email: wwoo@hms.harvard.edu, wwoo@hms.harvard.edu organization: Laboratory of Cellular Neuropathology, McLean Hospital |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24628518$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkU9v1DAQxS1URLeFb4BQjlyyOPHayXIAVSv-VCpQqeVszTpj4sqxg51sWT49jrKtgAP05MP83nueNyfkyHmHhDwv6JIVdP2KFqKqqGDLkhZsWVc1Y-tHZFFwwXJeCnpEFhOST8wxOYnxhiZQlOIJOS5Xoqx5US-I-eQtqtFCyC6D18ZizLzOLiHswG7Hzrj8vOtG5wOCGswOs884Bu9iZlw2tJhdjT0G40N2jV3vA9hs48OAP6b5lWrNT9-3AZ2Bp-SxBhvx2eE9JV_fv7vefMwvvnw435xd5IrXfMgrzQQ02zUqXdS0LoWqq0ZvkVMFTK-Q8ho5MCGAAoDWHCDVwBPZlJSuGTslfPYdXQ_7W7BW9sF0EPayoHKqTt5VJ6fq5Fxd0r2Zdf247bBR6Ia0zb3Wg5F_Tpxp5Te_kyvBWHJMBi8PBsF_HzEOsjNRobXg0I9RFrxMQVW1pgl98XvWfcjdXRLwegZU8DEG1FKZAQbjp2hj_7fJ6i_xAwt4O8uM0z50cOuDbeQAe-uDDuCUiZP6IRUeHFoEO7QKAsobPwaXzv7vL_wChFHb7A |
CitedBy_id | crossref_primary_10_1111_jnc_13637 crossref_primary_10_1038_s41398_021_01707_x crossref_primary_10_3389_fncel_2023_1188574 crossref_primary_10_1002_jnr_25188 crossref_primary_10_1016_j_biopsych_2018_07_010 crossref_primary_10_1038_s41467_020_16218_4 crossref_primary_10_1016_j_schres_2015_10_042 crossref_primary_10_1038_s41398_019_0647_7 crossref_primary_10_1016_j_schres_2015_10_002 crossref_primary_10_1007_s12640_015_9543_y crossref_primary_10_3390_genes15050609 crossref_primary_10_1038_s41380_022_01662_z crossref_primary_10_1016_j_jpsychires_2018_03_013 crossref_primary_10_1016_j_neuroscience_2014_12_013 crossref_primary_10_1016_j_jpsychires_2021_05_029 crossref_primary_10_1016_j_neubiorev_2017_04_003 crossref_primary_10_1038_mp_2016_147 crossref_primary_10_1093_ijnp_pyv088 crossref_primary_10_1038_s41380_021_01374_w crossref_primary_10_1016_j_neures_2023_01_012 crossref_primary_10_1007_s12017_023_08743_4 crossref_primary_10_1038_mp_2017_216 crossref_primary_10_1038_s41593_020_0604_z crossref_primary_10_1016_j_euroneuro_2016_01_009 crossref_primary_10_1093_schbul_sbad080 crossref_primary_10_1371_journal_pone_0200003 crossref_primary_10_1016_j_pneurobio_2017_03_004 crossref_primary_10_3389_fnins_2019_00164 crossref_primary_10_3390_medicina60081271 crossref_primary_10_1038_nrd_2016_28 crossref_primary_10_1016_j_schres_2016_10_024 crossref_primary_10_1080_15622975_2023_2211653 crossref_primary_10_1016_j_pnpbp_2016_03_010 crossref_primary_10_1016_j_pharmthera_2016_07_006 crossref_primary_10_1016_j_jpsychires_2023_01_005 crossref_primary_10_1007_s10571_021_01089_0 crossref_primary_10_1016_j_biopsych_2014_12_028 crossref_primary_10_1111_ejn_14934 crossref_primary_10_1002_jnr_23550 crossref_primary_10_1016_j_schres_2016_12_017 crossref_primary_10_1016_j_neures_2021_12_006 crossref_primary_10_1016_j_ymeth_2022_08_013 crossref_primary_10_1016_j_mcn_2015_11_009 crossref_primary_10_1038_s41467_019_12576_w crossref_primary_10_1523_JNEUROSCI_1634_20_2020 crossref_primary_10_1080_15622975_2016_1224929 crossref_primary_10_1038_srep37580 crossref_primary_10_1007_s13311_017_0552_9 crossref_primary_10_3233_NIB_160110 crossref_primary_10_1038_s41398_020_01052_5 crossref_primary_10_1016_j_neubiorev_2023_105206 crossref_primary_10_1016_j_biopsych_2016_03_1047 crossref_primary_10_1038_s41380_019_0601_3 |
Cites_doi | 10.1016/j.conb.2010.12.002 10.1016/j.neubiorev.2010.10.008 10.2741/2077 10.1523/JNEUROSCI.5736-09.2010 10.1016/j.nbd.2006.01.003 10.3389/neuro.07.017.2009 10.1016/j.cell.2011.12.038 10.1038/nrn3024 10.1093/hmg/ddn005 10.1089/ars.2012.4858 10.1101/SQB.1990.055.01.088 10.1016/j.neuropharm.2011.01.049 10.1038/emboj.2012.124 10.1016/j.tins.2008.02.005 10.1083/jcb.200511054 10.1016/j.neuron.2009.04.022 10.1242/dev.01724 10.1016/j.ceb.2012.01.010 10.1038/onc.2010.186 10.1016/j.ydbio.2004.08.039 10.1038/nrn1648 10.1002/(SICI)1097-4652(199912)181:3<393::AID-JCP3>3.0.CO;2-6 10.1038/npp.2008.19 10.1093/brain/awn323 10.1523/JNEUROSCI.23-15-06315.2003 10.1128/MCB.23.4.1379-1389.2003 10.1016/j.neuropharm.2010.12.011 10.3109/10673221003747609 10.1159/000178017 10.1093/cercor/bhs159 10.1016/S0092-8674(00)80689-3 10.1016/j.schres.2011.01.018 10.1073/pnas.95.9.5341 10.1016/j.neuropharm.2009.06.002 10.1007/s004410100396 10.1523/JNEUROSCI.17-04-01256.1997 10.1016/S0165-3806(02)00277-8 10.1016/S0002-9440(10)64672-X 10.1016/j.biopsych.2011.10.004 10.1093/nar/28.1.27 10.1016/j.tins.2011.10.004 10.1038/nrn2774 10.1073/pnas.1300454110 10.1093/nar/gkj102 10.1523/JNEUROSCI.4722-05.2006 10.1073/pnas.0810153105 10.1007/s11920-010-0124-8 10.1016/j.biopsych.2010.09.039 10.1016/S0006-3223(98)00138-3 10.1176/ajp.154.7.1013 10.1093/nar/gkp896 10.1007/978-1-61779-163-5_28 10.1091/mbc.E08-09-0939 10.1385/MN:27:2:153 10.1073/pnas.1018132108 10.1016/j.nlm.2007.04.006 10.1016/j.gde.2012.05.001 10.1152/physrev.00035.2008 10.1016/j.biopsych.2012.09.020 10.1073/pnas.1113793109 10.1113/jphysiol.2011.224659 10.1016/B978-0-12-385975-4.00011-5 10.1016/j.biopsych.2010.09.030 10.1016/j.neuroscience.2005.10.014 10.1176/appi.ajp.2011.11010052 10.1038/emboj.2012.145 10.1038/nrn2755 10.1242/dev.02008 10.1073/pnas.0308126101 10.1016/j.ydbio.2004.01.014 10.1016/j.leukres.2008.10.026 10.1016/S0165-6147(03)00100-7 10.1016/S0166-2236(00)01663-5 10.1016/j.yexcr.2008.03.017 10.1186/1471-2105-7-333 10.1016/S0006-3223(98)00281-9 10.1016/S0893-133X(01)00225-1 10.1073/pnas.96.10.5522 10.1074/jbc.M511920200 10.1083/jcb.152.1.87 10.1176/ajp.156.11.1709 10.1007/BF03033813 10.1002/mc.20728 10.1038/npp.2011.102 10.1007/s13277-010-0078-9 10.1016/j.conb.2009.05.001 10.1038/15124 10.1016/j.nbd.2009.09.003 10.1523/JNEUROSCI.3055-06.2007 10.4161/cc.21138 10.1001/archpsyc.1991.01810350036005 10.3389/neuro.09.033.2009 10.1073/pnas.0703806104 10.1007/BF01255817 10.1021/pr900867x 10.1016/j.neuropharm.2011.01.022 10.1073/pnas.0406074101 10.1074/jbc.M500562200 10.1038/nature09915 10.1038/nrn1519 10.1523/JNEUROSCI.2213-07.2007 |
ContentType | Journal Article |
Copyright | 2014 Informa Healthcare USA, Inc. 2014 |
Copyright_xml | – notice: 2014 Informa Healthcare USA, Inc. 2014 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM ADTOC UNPAY |
DOI | 10.3109/01677063.2013.878339 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1563-5260 |
EndPage | 85 |
ExternalDocumentID | oai:pubmedcentral.nih.gov:4633016 PMC4633016 24628518 10_3109_01677063_2013_878339 878339 |
Genre | Research Article Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIMH NIH HHS grantid: P50MH080272 – fundername: NIMH NIH HHS grantid: R01MH076060 – fundername: NCRR NIH HHS grantid: P51 RR000168 – fundername: NIMH NIH HHS grantid: R01 MH076060 – fundername: NIMH NIH HHS grantid: P50 MH080272 |
GroupedDBID | --- -~X .GJ 00X 03L 0BK 0R~ 29L 36B 4.4 53G 5GY 5RE 5VS AAFWK AAGKR AAJNR AALIY AALUX AAOTW AAPUL AAPXX AAQRR ABBKH ABDBF ABEIZ ABEJY ABJNI ABKIK ABLIJ ABLKL ABUPF ABXYU ACENM ACFUF ACGEJ ACGFS ACLSK ADCVX ADFCX ADRBQ ADXPE ADXRV AECIN AENEX AEOZL AEQML AEYQI AFFVI AFKVX AFWLO AGDLA AGFJD AGRBW AGYJP AIJEM AIRBT AJWEG AKBVH ALIIL ALMA_UNASSIGNED_HOLDINGS ALQZU AMDAE AWYRJ AXVGA BABNJ BALJE BEYMU BLEHA BOHLJ BSQBA CAG CCCUG COF CS3 CXMEQ DKSSO DU5 EAP EBC EBD EBS EJD EMB EMK EMOBN EPL EST ESX F5P HMXZC HZ~ KRBQP KWAYT KYCEM LJTGL M44 M4Z O9- P2P RNANH RVRKI S70 SV3 TFDNU TFL TFW TUS TWFNG UEQFS V1S ZGI ~1N AAMIU ACIEZ ACUHS ALYBC H13 TBQAZ TDBHL TERGH TUROJ AAGDL AAYXX ABWVI ACGWS ACSXF ACUYY ADSTP AFRVT CITATION NUSFT TASJS ADYSH CGR CUY CVF ECM EIF NPM 7X8 5PM ADTOC UNPAY |
ID | FETCH-LOGICAL-c585t-7f36adb9ecf180826c87dfbe50ca3f4e058e5a366a0aaaff5aa7705082d200933 |
IEDL.DBID | UNPAY |
ISSN | 0167-7063 1563-5260 1026-8057 |
IngestDate | Tue Aug 19 23:56:07 EDT 2025 Tue Sep 30 16:21:18 EDT 2025 Thu Sep 04 15:15:31 EDT 2025 Mon Jul 21 06:07:24 EDT 2025 Thu Apr 24 23:01:23 EDT 2025 Wed Oct 01 02:54:38 EDT 2025 Wed Dec 25 09:05:49 EST 2024 Wed Jan 31 10:30:19 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1-2 |
Keywords | cerebral cortex microRNA gene expression profiling laser capture microdissection |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c585t-7f36adb9ecf180826c87dfbe50ca3f4e058e5a366a0aaaff5aa7705082d200933 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=http://doi.org/10.3109/01677063.2013.878339 |
PMID | 24628518 |
PQID | 1528337790 |
PQPubID | 23479 |
PageCount | 16 |
ParticipantIDs | pubmed_primary_24628518 informahealthcare_journals_10_3109_01677063_2013_878339 crossref_citationtrail_10_3109_01677063_2013_878339 unpaywall_primary_10_3109_01677063_2013_878339 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4633016 crossref_primary_10_3109_01677063_2013_878339 informaworld_taylorfrancis_310_3109_01677063_2013_878339 proquest_miscellaneous_1528337790 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 6/1/2014 |
PublicationDateYYYYMMDD | 2014-06-01 |
PublicationDate_xml | – month: 06 year: 2014 text: 6/1/2014 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Journal of neurogenetics |
PublicationTitleAlternate | J Neurogenet |
PublicationYear | 2014 |
Publisher | Informa Healthcare Taylor & Francis |
Publisher_xml | – name: Informa Healthcare – name: Taylor & Francis |
References | Chen S. (CIT0022) 2001; 152 Lisman J. E. (CIT0063) 2008; 31 CIT0074 Shtutman M. (CIT0090) 1999; 96 Woo T. U. W. (CIT0103) 1997; 154 Luzzi V. (CIT0065) 2001; 158 Danesin C. (CIT0030) 2012; 22 Wang X. J (CIT0101) 2010; 90 Niehrs C. (CIT0078) 2012; 31 Conboy L. (CIT0025) 2007; 88 Selemon L. D. (CIT0089) 1999; 45 Hall A. C. (CIT0039) 2000; 100 Fan Y. (CIT0033) 2012; 71 Carro E. (CIT0020) 2003; 27 Jensen M. (CIT0047) 2012; 149 Cabungcal J. H. (CIT0016) 2013; 73 Benes F. M. (CIT0010) 1991; 48 Sahores M. (CIT0087) 2011; 97 Benes F. M (CIT0005) 2011; 60 Uhlhaas P. J. (CIT0098) 2009; 3 Ishitani T. (CIT0045) 2003; 23 Markram H. (CIT0068) 2004; 5 Das A. V. (CIT0031) 2008; 30 Budnik V. (CIT0014) 2011; 21 CIT0081 Benes F. M. (CIT0006) 2001; 25 Gogolla N. (CIT0036) 2009; 62 Soltesz I (CIT0093) 2005 Miele L. (CIT0071) 1999; 181 Inestrosa N. C. (CIT0044) 2010; 11 Lewis D. A. (CIT0060) 2005; 6 Powell S. B. (CIT0085) 2011; 62 CIT0007 Santarelli D. M. (CIT0088) 2011; 69 Hayward P. (CIT0042) 2005; 132 CIT0094 Cuitino L. (CIT0027) 2010; 30 Pietersen C. Y. (CIT0083) 2011; 755 Hashimoto T. (CIT0041) 2003; 23 Lewis D. A. (CIT0057) 2011; 35 Singer W. (CIT0092) 1990; 55 Park D. S. (CIT0080) 1997; 17 Chen J. (CIT0021) 2006; 281 Kaiya H. (CIT0048) 1989; 77 Cabungcal J. H. (CIT0015) 2006; 22 Neves G. (CIT0077) 2012; 23 Tiberi L. (CIT0097) 2012; 24 Katsel P. (CIT0052) 2008; 33 Bitanihirwe B. K. (CIT0012) 2011; 35 Liodis P. (CIT0062) 2007; 27 Ables J. L. (CIT0001) 2011; 12 Behrens M. M. (CIT0004) 2009; 57 Kinney J. W. (CIT0054) 2006; 26 Anderson M. F. (CIT0003) 2002; 134 Benes F. M. (CIT0008) 2008; 105 Liu D. X. (CIT0064) 2001; 305 Ling H. (CIT0061) 2010; 29 Caricasole A. (CIT0018) 2003; 24 Kaur J. (CIT0053) 2010; 31 CIT0037 Yang X. (CIT0106) 2004; 269 CIT0040 CIT0043 Rodriguez D. A. (CIT0086) 2009; 20 Steullet P. (CIT0096) 2006; 137 Cabungcal J. H. (CIT0017) 2013; 110 Ciani L. (CIT0024) 2011; 108 Malaterre J. (CIT0067) 2007; 12 Muller N (CIT0075) 2010; 11 CIT0046 Kulak A. (CIT0055) 2013; 18 Glausier J. R. (CIT0035) 2011; 36 Lewis D. A. (CIT0059) 2008; 14 Martinez-Gras I. (CIT0069) 2011; 128 Ahmad-Annuar A. (CIT0002) 2006; 174 Pierri J. N. (CIT0082) 1999; 156 Do K. Q. (CIT0032) 2009; 19 CIT0050 CIT0051 Pietersen C. Y. (CIT0084) 2009; 30 Carlson M. E. (CIT0019) 2008; 314 Benes F. M. (CIT0009) 2007; 104 Curley A. A. (CIT0028) 2011; 168 Letamendia A. (CIT0056) 2001; 83 Freese J. L. (CIT0034) 2010; 38 Oishi K. (CIT0079) 2004; 276 Curley A. A. (CIT0029) 2012; 590 Beveridge N. J. (CIT0011) 2008; 17 Brennand K. J. (CIT0013) 2011; 473 CIT0058 Nakazawa K. (CIT0076) 2011; 62 Wang Y. (CIT0102) 2004; 101 Miron M. (CIT0073) 2006; 7 Miller B. H. (CIT0072) 2012; 109 Uhlhaas P. J. (CIT0099) 2010; 11 Spencer K. M. (CIT0095) 2004; 101 Simunovic F. (CIT0091) 2009; 132 Wang L. (CIT0100) 2010; 9 Woo T. U. W. (CIT0105) 1998; 95 Copani A. (CIT0026) 2001; 24 Chun K. S. (CIT0023) 2011; 50 CIT0104 Guo D. (CIT0038) 2009; 33 Mason H. A. (CIT0070) 2005; 132 Kanehisa M. (CIT0049) 2000; 28 Mahadevappa M. (CIT0066) 1999; 17 21632647 - Am J Psychiatry. 2011 Sep;168(9):921-9 16818724 - J Cell Biol. 2006 Jul 3;174(1):127-39 10553733 - Am J Psychiatry. 1999 Nov;156(11):1709-19 21183010 - Biol Psychiatry. 2011 Jan 15;69(2):188-93 20573888 - J Neurosci. 2010 Jun 23;30(25):8411-20 23671099 - Proc Natl Acad Sci U S A. 2013 May 28;110(22):9130-5 11263663 - J Bone Joint Surg Am. 2001;83-A Suppl 1(Pt 1):S31-9 11545259 - Cell Tissue Res. 2001 Aug;305(2):217-28 19244345 - Mol Biol Cell. 2009 Apr;20(8):2297-310 12777685 - Mol Neurobiol. 2003 Apr;27(2):153-62 22617425 - EMBO J. 2012 Jun 13;31(12):2705-13 19916557 - J Proteome Res. 2010 Jan;9(1):521-7 20562911 - Oncogene. 2010 Aug 12;29(32):4543-54 10318916 - Proc Natl Acad Sci U S A. 1999 May 11;96(10):5522-7 18184693 - Hum Mol Genet. 2008 Apr 15;17(8):1156-68 9894571 - Biol Psychiatry. 1999 Jan 1;45(1):17-25 11395378 - Am J Pathol. 2001 Jun;158(6):2005-10 15378039 - Nat Rev Neurosci. 2004 Oct;5(10):793-807 22074604 - Curr Top Dev Biol. 2011;97:119-36 16381885 - Nucleic Acids Res. 2006 Jan 1;34(Database issue):D354-7 20974172 - Neurosci Biobehav Rev. 2011 Jan;35(3):878-93 16822306 - BMC Bioinformatics. 2006;7:333 15803162 - Nat Rev Neurosci. 2005 Apr;6(4):312-24 19091404 - Leuk Res. 2009 May;33(5):678-85 21111402 - Biol Psychiatry. 2011 Jan 15;69(2):180-7 15855163 - J Biol Chem. 2005 Jun 24;280(25):24053-63 19052140 - Brain. 2009 Jul;132(Pt 7):1795-809 20010950 - Nat Rev Neurosci. 2010 Feb;11(2):77-86 17959792 - J Neurosci. 2007 Oct 24;27(43):11496-500 12867516 - J Neurosci. 2003 Jul 16;23(15):6315-26 22938092 - Antioxid Redox Signal. 2013 Apr 20;18(12):1428-43 17543552 - Neurobiol Learn Mem. 2007 Oct;88(3):342-51 20664082 - Physiol Rev. 2010 Jul;90(3):1195-268 22781061 - Cell Cycle. 2012 Jul 15;11(14):2585-6 17376969 - J Neurosci. 2007 Mar 21;27(12):3078-89 10721990 - Cell. 2000 Mar 3;100(5):525-35 22154068 - Trends Neurosci. 2012 Jan;35(1):57-67 19104056 - Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20935-40 19668703 - Front Integr Neurosci. 2009 Jul 30;3:17 19523965 - Neuropharmacology. 2009 Sep;57(3):193-200 19765659 - Neurobiol Dis. 2010 May;38(2):148-53 16120638 - Development. 2005 Oct;132(19):4247-58 21761317 - Methods Mol Biol. 2011;755:327-43 16481179 - Neurobiol Dis. 2006 Jun;22(3):624-37 11947942 - Brain Res Dev Brain Res. 2002 Mar 31;134(1-2):115-22 20047157 - Curr Opin Investig Drugs. 2010 Jan;11(1):31-42 22617419 - EMBO J. 2012 Jun 13;31(12):2697-704 22710612 - Cereb Cortex. 2013 Aug;23(8):1811-23 20415633 - Harv Rev Psychiatry. 2010 May-Jun;18(3):173-89 21315745 - Neuropharmacology. 2012 Mar;62(3):1322-31 16501258 - J Biol Chem. 2006 Apr 28;281(17):11910-6 21277876 - Neuropharmacology. 2012 Mar;62(3):1574-83 21670302 - Proc Natl Acad Sci U S A. 2011 Jun 28;108(26):10732-7 22342580 - Curr Opin Cell Biol. 2012 Apr;24(2):269-76 2132871 - Cold Spring Harb Symp Quant Biol. 1990;55:939-52 11149923 - J Cell Biol. 2001 Jan 8;152(1):87-96 21184762 - Neuropharmacology. 2011 Jun;60(7-8):1232-42 17553960 - Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10164-9 20617408 - Tumour Biol. 2010 Dec;31(6):623-31 11163884 - Trends Neurosci. 2001 Jan;24(1):25-31 22074612 - Biol Psychiatry. 2012 Jan 15;71(2):129-35 10592173 - Nucleic Acids Res. 2000 Jan 1;28(1):27-30 18474281 - Exp Cell Res. 2008 Jun 10;314(9):1951-61 20087360 - Nat Rev Neurosci. 2010 Feb;11(2):100-13 19073429 - Neurotox Res. 2008 Oct;14(2-3):237-48 19477153 - Neuron. 2009 May 28;62(4):510-25 19684564 - J Vis Exp. 2009;(30). pii: 1444. doi: 10.3791/1444 10545926 - Nat Biotechnol. 1999 Nov;17(11):1134-6 15546988 - Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17288-93 21268125 - Mol Carcinog. 2011 Jun;50(6):439-48 12767722 - Trends Pharmacol Sci. 2003 May;24(5):233-8 21505516 - Nat Rev Neurosci. 2011 May;12(5):269-83 15531372 - Dev Biol. 2004 Dec 1;276(1):172-84 19481443 - Curr Opin Neurobiol. 2009 Apr;19(2):220-30 11377916 - Neuropsychopharmacology. 2001 Jul;25(1):1-27 15772135 - Development. 2005 Apr;132(8):1819-30 19880382 - Nucleic Acids Res. 2010 Jan;38(Database issue):D355-60 19876408 - Front Hum Neurosci. 2009 Oct 20;3:33 23140664 - Biol Psychiatry. 2013 Mar 15;73(6):574-82 21677653 - Neuropsychopharmacology. 2011 Sep;36(10):2103-10 22315408 - Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3125-30 9646890 - Biol Psychiatry. 1998 Jul 15;44(2):88-97 9560277 - Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5341-6 19033687 - Dev Neurosci. 2008;30(6):389-409 9210755 - Am J Psychiatry. 1997 Jul;154(7):1013-5 15081359 - Dev Biol. 2004 May 1;269(1):81-94 21334179 - Schizophr Res. 2011 May;128(1-3):15-22 18395805 - Trends Neurosci. 2008 May;31(5):234-42 9006970 - J Neurosci. 1997 Feb 15;17(4):1256-70 10528225 - J Cell Physiol. 1999 Dec;181(3):393-409 21239163 - Curr Opin Neurobiol. 2011 Feb;21(1):151-9 20556669 - Curr Psychiatry Rep. 2010 Aug;12(4):335-44 21490598 - Nature. 2011 May 12;473(7346):221-5 12556497 - Mol Cell Biol. 2003 Feb;23(4):1379-89 2746199 - J Neural Transm. 1989;77(1):39-46 22464329 - Cell. 2012 Mar 30;149(1):173-87 17127312 - Front Biosci. 2007;12:492-506 16452684 - J Neurosci. 2006 Feb 1;26(5):1604-15 1747023 - Arch Gen Psychiatry. 1991 Nov;48(11):996-1001 22219337 - J Physiol. 2012 Feb 15;590(4):715-24 16330153 - Neuroscience. 2006 Feb;137(3):807-19 15190179 - Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9458-62 22742851 - Curr Opin Genet Dev. 2012 Aug;22(4):323-30 18322470 - Neuropsychopharmacology. 2008 Nov;33(12):2993-3009 |
References_xml | – volume: 21 start-page: 151 year: 2011 ident: CIT0014 publication-title: Curr Opin Neurobiol doi: 10.1016/j.conb.2010.12.002 – volume: 35 start-page: 878 year: 2011 ident: CIT0012 publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2010.10.008 – volume: 12 start-page: 492 year: 2007 ident: CIT0067 publication-title: Front Biosci doi: 10.2741/2077 – volume: 30 start-page: 8411 year: 2010 ident: CIT0027 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.5736-09.2010 – volume: 22 start-page: 624 year: 2006 ident: CIT0015 publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2006.01.003 – volume: 3 start-page: 17 year: 2009 ident: CIT0098 publication-title: Front Integr Neurosci doi: 10.3389/neuro.07.017.2009 – volume: 149 start-page: 173 year: 2012 ident: CIT0047 publication-title: Cell doi: 10.1016/j.cell.2011.12.038 – volume: 12 start-page: 269 year: 2011 ident: CIT0001 publication-title: Nat Rev Neurosci doi: 10.1038/nrn3024 – volume: 17 start-page: 1156 year: 2008 ident: CIT0011 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddn005 – volume: 18 start-page: 1428 year: 2013 ident: CIT0055 publication-title: Antioxid Redox Signal doi: 10.1089/ars.2012.4858 – volume: 55 start-page: 939 year: 1990 ident: CIT0092 publication-title: Cold Spring Harb Symp Quant Biol doi: 10.1101/SQB.1990.055.01.088 – volume: 62 start-page: 1322 year: 2011 ident: CIT0085 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2011.01.049 – volume: 31 start-page: 2705 year: 2012 ident: CIT0078 publication-title: EMBO J doi: 10.1038/emboj.2012.124 – volume: 31 start-page: 234 year: 2008 ident: CIT0063 publication-title: Trends Neurosci doi: 10.1016/j.tins.2008.02.005 – volume: 174 start-page: 127 year: 2006 ident: CIT0002 publication-title: J Cell Biol doi: 10.1083/jcb.200511054 – volume: 11 start-page: 31 year: 2010 ident: CIT0075 publication-title: Curr Opin Investig Drugs – volume: 62 start-page: 510 year: 2009 ident: CIT0036 publication-title: Neuron doi: 10.1016/j.neuron.2009.04.022 – volume: 132 start-page: 1819 year: 2005 ident: CIT0042 publication-title: Development doi: 10.1242/dev.01724 – volume: 24 start-page: 269 year: 2012 ident: CIT0097 publication-title: Curr Opin Cell Biol doi: 10.1016/j.ceb.2012.01.010 – volume: 29 start-page: 4543 year: 2010 ident: CIT0061 publication-title: Oncogene doi: 10.1038/onc.2010.186 – volume: 276 start-page: 172 year: 2004 ident: CIT0079 publication-title: Dev Biol doi: 10.1016/j.ydbio.2004.08.039 – volume: 6 start-page: 312 year: 2005 ident: CIT0060 publication-title: Nat Rev Neurosci doi: 10.1038/nrn1648 – volume: 181 start-page: 393 year: 1999 ident: CIT0071 publication-title: J Cell Physiol doi: 10.1002/(SICI)1097-4652(199912)181:3<393::AID-JCP3>3.0.CO;2-6 – volume: 33 start-page: 2993 year: 2008 ident: CIT0052 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2008.19 – volume: 132 start-page: 1795 issue: 7 year: 2009 ident: CIT0091 publication-title: Brain doi: 10.1093/brain/awn323 – volume: 23 start-page: 6315 year: 2003 ident: CIT0041 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.23-15-06315.2003 – volume: 23 start-page: 1379 year: 2003 ident: CIT0045 publication-title: Mol Cell Biol doi: 10.1128/MCB.23.4.1379-1389.2003 – volume-title: Diversity in the neuronal machine year: 2005 ident: CIT0093 – volume: 60 start-page: 1232 year: 2011 ident: CIT0005 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2010.12.011 – ident: CIT0104 doi: 10.3109/10673221003747609 – volume: 30 start-page: 389 year: 2008 ident: CIT0031 publication-title: Dev Neurosci doi: 10.1159/000178017 – volume: 23 start-page: 1811 year: 2012 ident: CIT0077 publication-title: Cereb Cortex doi: 10.1093/cercor/bhs159 – volume: 100 start-page: 525 year: 2000 ident: CIT0039 publication-title: Cell doi: 10.1016/S0092-8674(00)80689-3 – volume: 128 start-page: 15 year: 2011 ident: CIT0069 publication-title: Schizophr Res doi: 10.1016/j.schres.2011.01.018 – volume: 30 year: 2009 ident: CIT0084 publication-title: J Vis Exp – volume: 95 start-page: 5341 year: 1998 ident: CIT0105 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.95.9.5341 – volume: 57 start-page: 193 year: 2009 ident: CIT0004 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2009.06.002 – volume: 305 start-page: 217 year: 2001 ident: CIT0064 publication-title: Cell Tissue Res doi: 10.1007/s004410100396 – volume: 17 start-page: 1256 year: 1997 ident: CIT0080 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.17-04-01256.1997 – volume: 134 start-page: 115 year: 2002 ident: CIT0003 publication-title: Brain Res Dev Brain Res doi: 10.1016/S0165-3806(02)00277-8 – volume: 158 start-page: 2005 year: 2001 ident: CIT0065 publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)64672-X – volume: 71 start-page: 129 year: 2012 ident: CIT0033 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2011.10.004 – volume: 28 start-page: 27 year: 2000 ident: CIT0049 publication-title: Nucleic Acids Res doi: 10.1093/nar/28.1.27 – volume: 35 start-page: 57 year: 2011 ident: CIT0057 publication-title: Trends Neurosci doi: 10.1016/j.tins.2011.10.004 – volume: 11 start-page: 100 year: 2010 ident: CIT0099 publication-title: Nat Rev Neurosci doi: 10.1038/nrn2774 – volume: 110 start-page: 9130 year: 2013 ident: CIT0017 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1300454110 – ident: CIT0051 doi: 10.1093/nar/gkj102 – volume: 26 start-page: 1604 year: 2006 ident: CIT0054 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4722-05.2006 – volume: 105 start-page: 20935 year: 2008 ident: CIT0008 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0810153105 – ident: CIT0037 doi: 10.1007/s11920-010-0124-8 – ident: CIT0074 doi: 10.1016/j.biopsych.2010.09.039 – ident: CIT0007 doi: 10.1016/S0006-3223(98)00138-3 – volume: 154 start-page: 1013 year: 1997 ident: CIT0103 publication-title: Am J Psychiatry doi: 10.1176/ajp.154.7.1013 – ident: CIT0050 doi: 10.1093/nar/gkp896 – volume: 755 start-page: 327 year: 2011 ident: CIT0083 publication-title: Methods Mol Biol doi: 10.1007/978-1-61779-163-5_28 – volume: 20 start-page: 2297 year: 2009 ident: CIT0086 publication-title: Mol Biol Cell doi: 10.1091/mbc.E08-09-0939 – volume: 27 start-page: 153 year: 2003 ident: CIT0020 publication-title: Mol Neurobiol doi: 10.1385/MN:27:2:153 – volume: 108 start-page: 10732 year: 2011 ident: CIT0024 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1018132108 – volume: 88 start-page: 342 year: 2007 ident: CIT0025 publication-title: Neurobiol Learn Mem doi: 10.1016/j.nlm.2007.04.006 – volume: 22 start-page: 323 year: 2012 ident: CIT0030 publication-title: Curr Opin Genet Dev doi: 10.1016/j.gde.2012.05.001 – volume: 90 start-page: 1195 year: 2010 ident: CIT0101 publication-title: Physiol Rev doi: 10.1152/physrev.00035.2008 – volume: 73 start-page: 574 year: 2013 ident: CIT0016 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2012.09.020 – volume: 109 start-page: 3125 year: 2012 ident: CIT0072 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1113793109 – volume: 590 start-page: 715 issue: 4 year: 2012 ident: CIT0029 publication-title: J Physiol doi: 10.1113/jphysiol.2011.224659 – volume: 97 start-page: 119 year: 2011 ident: CIT0087 publication-title: Curr Top Dev Biol doi: 10.1016/B978-0-12-385975-4.00011-5 – volume: 69 start-page: 180 year: 2011 ident: CIT0088 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2010.09.030 – volume: 137 start-page: 807 year: 2006 ident: CIT0096 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2005.10.014 – volume: 168 start-page: 921 year: 2011 ident: CIT0028 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2011.11010052 – ident: CIT0081 doi: 10.1038/emboj.2012.145 – volume: 11 start-page: 77 year: 2010 ident: CIT0044 publication-title: Nat Rev Neurosci doi: 10.1038/nrn2755 – volume: 132 start-page: 4247 year: 2005 ident: CIT0070 publication-title: Development doi: 10.1242/dev.02008 – volume: 101 start-page: 9458 year: 2004 ident: CIT0102 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0308126101 – volume: 269 start-page: 81 year: 2004 ident: CIT0106 publication-title: Dev Biol doi: 10.1016/j.ydbio.2004.01.014 – volume: 33 start-page: 678 year: 2009 ident: CIT0038 publication-title: Leuk Res doi: 10.1016/j.leukres.2008.10.026 – volume: 24 start-page: 233 year: 2003 ident: CIT0018 publication-title: Trends Pharmacol Sci doi: 10.1016/S0165-6147(03)00100-7 – volume: 24 start-page: 25 year: 2001 ident: CIT0026 publication-title: Trends Neurosci doi: 10.1016/S0166-2236(00)01663-5 – volume: 314 start-page: 1951 year: 2008 ident: CIT0019 publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2008.03.017 – volume: 7 start-page: 333 year: 2006 ident: CIT0073 publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-7-333 – volume: 45 start-page: 17 year: 1999 ident: CIT0089 publication-title: Biol Psychiatry doi: 10.1016/S0006-3223(98)00281-9 – volume: 25 start-page: 1 year: 2001 ident: CIT0006 publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(01)00225-1 – volume: 96 start-page: 5522 year: 1999 ident: CIT0090 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.96.10.5522 – ident: CIT0058 doi: 10.1016/j.tins.2011.10.004 – volume: 281 start-page: 11910 year: 2006 ident: CIT0021 publication-title: J Biol Chem doi: 10.1074/jbc.M511920200 – volume: 152 start-page: 87 year: 2001 ident: CIT0022 publication-title: J Cell Biol doi: 10.1083/jcb.152.1.87 – volume: 156 start-page: 1709 year: 1999 ident: CIT0082 publication-title: Am J Psychiatry doi: 10.1176/ajp.156.11.1709 – volume: 14 start-page: 237 year: 2008 ident: CIT0059 publication-title: Neurotox Res doi: 10.1007/BF03033813 – volume: 83 start-page: S31 issue: 1 year: 2001 ident: CIT0056 publication-title: J Bone Joint Surg Am – volume: 50 start-page: 439 year: 2011 ident: CIT0023 publication-title: Mol Carcinog doi: 10.1002/mc.20728 – volume: 36 start-page: 2103 year: 2011 ident: CIT0035 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2011.102 – volume: 31 start-page: 623 year: 2010 ident: CIT0053 publication-title: Tumour Biol doi: 10.1007/s13277-010-0078-9 – volume: 19 start-page: 220 year: 2009 ident: CIT0032 publication-title: Curr Opin Neurobiol doi: 10.1016/j.conb.2009.05.001 – volume: 17 start-page: 1134 year: 1999 ident: CIT0066 publication-title: Nat Biotechnol doi: 10.1038/15124 – volume: 38 start-page: 148 year: 2010 ident: CIT0034 publication-title: Neurobiol Dis doi: 10.1016/j.nbd.2009.09.003 – volume: 27 start-page: 3078 year: 2007 ident: CIT0062 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.3055-06.2007 – ident: CIT0046 doi: 10.4161/cc.21138 – volume: 48 start-page: 996 year: 1991 ident: CIT0010 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.1991.01810350036005 – ident: CIT0094 doi: 10.3389/neuro.09.033.2009 – volume: 104 start-page: 10164 year: 2007 ident: CIT0009 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0703806104 – volume: 77 start-page: 39 year: 1989 ident: CIT0048 publication-title: J Neural Transm doi: 10.1007/BF01255817 – volume: 9 start-page: 521 year: 2010 ident: CIT0100 publication-title: J Proteome Res doi: 10.1021/pr900867x – volume: 62 start-page: 1574 year: 2011 ident: CIT0076 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2011.01.022 – volume: 101 start-page: 17288 year: 2004 ident: CIT0095 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0406074101 – ident: CIT0040 doi: 10.1074/jbc.M500562200 – volume: 473 start-page: 221 year: 2011 ident: CIT0013 publication-title: Nature doi: 10.1038/nature09915 – volume: 5 start-page: 793 year: 2004 ident: CIT0068 publication-title: Nat Rev Neurosci doi: 10.1038/nrn1519 – ident: CIT0043 doi: 10.1523/JNEUROSCI.2213-07.2007 – reference: 19880382 - Nucleic Acids Res. 2010 Jan;38(Database issue):D355-60 – reference: 19073429 - Neurotox Res. 2008 Oct;14(2-3):237-48 – reference: 9210755 - Am J Psychiatry. 1997 Jul;154(7):1013-5 – reference: 10553733 - Am J Psychiatry. 1999 Nov;156(11):1709-19 – reference: 16818724 - J Cell Biol. 2006 Jul 3;174(1):127-39 – reference: 20664082 - Physiol Rev. 2010 Jul;90(3):1195-268 – reference: 16330153 - Neuroscience. 2006 Feb;137(3):807-19 – reference: 22154068 - Trends Neurosci. 2012 Jan;35(1):57-67 – reference: 15803162 - Nat Rev Neurosci. 2005 Apr;6(4):312-24 – reference: 16501258 - J Biol Chem. 2006 Apr 28;281(17):11910-6 – reference: 19684564 - J Vis Exp. 2009;(30). pii: 1444. doi: 10.3791/1444 – reference: 9894571 - Biol Psychiatry. 1999 Jan 1;45(1):17-25 – reference: 11947942 - Brain Res Dev Brain Res. 2002 Mar 31;134(1-2):115-22 – reference: 22938092 - Antioxid Redox Signal. 2013 Apr 20;18(12):1428-43 – reference: 12767722 - Trends Pharmacol Sci. 2003 May;24(5):233-8 – reference: 21315745 - Neuropharmacology. 2012 Mar;62(3):1322-31 – reference: 16481179 - Neurobiol Dis. 2006 Jun;22(3):624-37 – reference: 19765659 - Neurobiol Dis. 2010 May;38(2):148-53 – reference: 20415633 - Harv Rev Psychiatry. 2010 May-Jun;18(3):173-89 – reference: 19091404 - Leuk Res. 2009 May;33(5):678-85 – reference: 10721990 - Cell. 2000 Mar 3;100(5):525-35 – reference: 21111402 - Biol Psychiatry. 2011 Jan 15;69(2):180-7 – reference: 22781061 - Cell Cycle. 2012 Jul 15;11(14):2585-6 – reference: 15081359 - Dev Biol. 2004 May 1;269(1):81-94 – reference: 20974172 - Neurosci Biobehav Rev. 2011 Jan;35(3):878-93 – reference: 22464329 - Cell. 2012 Mar 30;149(1):173-87 – reference: 21761317 - Methods Mol Biol. 2011;755:327-43 – reference: 17127312 - Front Biosci. 2007;12:492-506 – reference: 21505516 - Nat Rev Neurosci. 2011 May;12(5):269-83 – reference: 15378039 - Nat Rev Neurosci. 2004 Oct;5(10):793-807 – reference: 9560277 - Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5341-6 – reference: 21277876 - Neuropharmacology. 2012 Mar;62(3):1574-83 – reference: 23140664 - Biol Psychiatry. 2013 Mar 15;73(6):574-82 – reference: 21268125 - Mol Carcinog. 2011 Jun;50(6):439-48 – reference: 12777685 - Mol Neurobiol. 2003 Apr;27(2):153-62 – reference: 9006970 - J Neurosci. 1997 Feb 15;17(4):1256-70 – reference: 21183010 - Biol Psychiatry. 2011 Jan 15;69(2):188-93 – reference: 22219337 - J Physiol. 2012 Feb 15;590(4):715-24 – reference: 16822306 - BMC Bioinformatics. 2006;7:333 – reference: 20562911 - Oncogene. 2010 Aug 12;29(32):4543-54 – reference: 11395378 - Am J Pathol. 2001 Jun;158(6):2005-10 – reference: 19876408 - Front Hum Neurosci. 2009 Oct 20;3:33 – reference: 9646890 - Biol Psychiatry. 1998 Jul 15;44(2):88-97 – reference: 22710612 - Cereb Cortex. 2013 Aug;23(8):1811-23 – reference: 20047157 - Curr Opin Investig Drugs. 2010 Jan;11(1):31-42 – reference: 20617408 - Tumour Biol. 2010 Dec;31(6):623-31 – reference: 2746199 - J Neural Transm. 1989;77(1):39-46 – reference: 16120638 - Development. 2005 Oct;132(19):4247-58 – reference: 1747023 - Arch Gen Psychiatry. 1991 Nov;48(11):996-1001 – reference: 19481443 - Curr Opin Neurobiol. 2009 Apr;19(2):220-30 – reference: 11263663 - J Bone Joint Surg Am. 2001;83-A Suppl 1(Pt 1):S31-9 – reference: 22342580 - Curr Opin Cell Biol. 2012 Apr;24(2):269-76 – reference: 19052140 - Brain. 2009 Jul;132(Pt 7):1795-809 – reference: 22074612 - Biol Psychiatry. 2012 Jan 15;71(2):129-35 – reference: 15772135 - Development. 2005 Apr;132(8):1819-30 – reference: 17543552 - Neurobiol Learn Mem. 2007 Oct;88(3):342-51 – reference: 19244345 - Mol Biol Cell. 2009 Apr;20(8):2297-310 – reference: 22742851 - Curr Opin Genet Dev. 2012 Aug;22(4):323-30 – reference: 10545926 - Nat Biotechnol. 1999 Nov;17(11):1134-6 – reference: 19033687 - Dev Neurosci. 2008;30(6):389-409 – reference: 19477153 - Neuron. 2009 May 28;62(4):510-25 – reference: 21184762 - Neuropharmacology. 2011 Jun;60(7-8):1232-42 – reference: 15531372 - Dev Biol. 2004 Dec 1;276(1):172-84 – reference: 18395805 - Trends Neurosci. 2008 May;31(5):234-42 – reference: 22074604 - Curr Top Dev Biol. 2011;97:119-36 – reference: 19104056 - Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20935-40 – reference: 2132871 - Cold Spring Harb Symp Quant Biol. 1990;55:939-52 – reference: 20010950 - Nat Rev Neurosci. 2010 Feb;11(2):77-86 – reference: 18474281 - Exp Cell Res. 2008 Jun 10;314(9):1951-61 – reference: 21677653 - Neuropsychopharmacology. 2011 Sep;36(10):2103-10 – reference: 20087360 - Nat Rev Neurosci. 2010 Feb;11(2):100-13 – reference: 15855163 - J Biol Chem. 2005 Jun 24;280(25):24053-63 – reference: 22315408 - Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3125-30 – reference: 17376969 - J Neurosci. 2007 Mar 21;27(12):3078-89 – reference: 10318916 - Proc Natl Acad Sci U S A. 1999 May 11;96(10):5522-7 – reference: 17553960 - Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10164-9 – reference: 16452684 - J Neurosci. 2006 Feb 1;26(5):1604-15 – reference: 21490598 - Nature. 2011 May 12;473(7346):221-5 – reference: 15190179 - Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9458-62 – reference: 22617419 - EMBO J. 2012 Jun 13;31(12):2697-704 – reference: 20573888 - J Neurosci. 2010 Jun 23;30(25):8411-20 – reference: 18322470 - Neuropsychopharmacology. 2008 Nov;33(12):2993-3009 – reference: 11377916 - Neuropsychopharmacology. 2001 Jul;25(1):1-27 – reference: 21334179 - Schizophr Res. 2011 May;128(1-3):15-22 – reference: 12556497 - Mol Cell Biol. 2003 Feb;23(4):1379-89 – reference: 19523965 - Neuropharmacology. 2009 Sep;57(3):193-200 – reference: 11149923 - J Cell Biol. 2001 Jan 8;152(1):87-96 – reference: 20556669 - Curr Psychiatry Rep. 2010 Aug;12(4):335-44 – reference: 18184693 - Hum Mol Genet. 2008 Apr 15;17(8):1156-68 – reference: 23671099 - Proc Natl Acad Sci U S A. 2013 May 28;110(22):9130-5 – reference: 21239163 - Curr Opin Neurobiol. 2011 Feb;21(1):151-9 – reference: 19668703 - Front Integr Neurosci. 2009 Jul 30;3:17 – reference: 17959792 - J Neurosci. 2007 Oct 24;27(43):11496-500 – reference: 19916557 - J Proteome Res. 2010 Jan;9(1):521-7 – reference: 15546988 - Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17288-93 – reference: 10592173 - Nucleic Acids Res. 2000 Jan 1;28(1):27-30 – reference: 10528225 - J Cell Physiol. 1999 Dec;181(3):393-409 – reference: 16381885 - Nucleic Acids Res. 2006 Jan 1;34(Database issue):D354-7 – reference: 12867516 - J Neurosci. 2003 Jul 16;23(15):6315-26 – reference: 21670302 - Proc Natl Acad Sci U S A. 2011 Jun 28;108(26):10732-7 – reference: 11545259 - Cell Tissue Res. 2001 Aug;305(2):217-28 – reference: 21632647 - Am J Psychiatry. 2011 Sep;168(9):921-9 – reference: 11163884 - Trends Neurosci. 2001 Jan;24(1):25-31 – reference: 22617425 - EMBO J. 2012 Jun 13;31(12):2705-13 |
SSID | ssj0013626 |
Score | 2.226421 |
Snippet | Abstract
Dysregulation of pyramidal cell network function by the soma- and axon-targeting inhibitory neurons that contain the calcium-binding protein... Dysregulation of pyramidal cell network function by the soma- and axon-targeting inhibitory neurons that contain the calcium-binding protein parvalbumin (PV)... |
SourceID | unpaywall pubmedcentral proquest pubmed crossref informaworld informahealthcare |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 70 |
SubjectTerms | Adult Aged Aged, 80 and over Calbindins - metabolism cerebral cortex Dinoprostone - genetics Dinoprostone - metabolism Female gene expression profiling Glial Fibrillary Acidic Protein - metabolism Humans laser capture microdissection Male microRNA MicroRNAs - genetics MicroRNAs - metabolism Middle Aged Neurons - metabolism Parvalbumins - genetics Parvalbumins - metabolism Receptor, Notch1 - genetics Receptor, Notch1 - metabolism Schizophrenia - genetics Schizophrenia - metabolism Schizophrenia - pathology Signal Transduction - genetics Temporal Lobe - pathology Wnt Proteins - genetics Wnt Proteins - metabolism Young Adult |
Title | Molecular Profiles of Parvalbumin-Immunoreactive Neurons in the Superior Temporal Cortex in Schizophrenia |
URI | https://www.tandfonline.com/doi/abs/10.3109/01677063.2013.878339 https://www.ncbi.nlm.nih.gov/pubmed/24628518 https://www.proquest.com/docview/1528337790 https://pubmed.ncbi.nlm.nih.gov/PMC4633016 http://doi.org/10.3109/01677063.2013.878339 |
UnpaywallVersion | submittedVersion |
Volume | 28 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1563-5260 dateEnd: 20241003 omitProxy: true ssIdentifier: ssj0013626 issn: 1563-5260 databaseCode: ABDBF dateStart: 20020101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlZ3db9MwEMAtaB_gBQbjo8AmIyHeUto6_shj91ENpE2VtkrjKXJTW6tWnGlNBOOv585OspYCG49VfKlyufju7PPvCPkgWGxinvEogQFR3Id3obSMI221Bu8hTeZxTccn4mgSfznn57ec7ZXte0RWfsIieQleFGuwWFdJxVjykLQF7ia1SHtyMh5-rendMvRNA4-JiF3P-ITkhEGqJXrh0Nxfb7nmlLYqZOlFU4D1G8b0T8HoZk3lo9Jd6ZvverFYcVijp-Ek-NJzDrFO5bJbFtNu9nOTAnkfXWyRJ1XgSofB0p6RB8Y9J9tDB0n7txv6kfpSUr9Gv03mx3XTXToOPcGXNLd0jH2IcEtg7qLPeC4lh4jVz7fUM0Lcks4dhYiUnpYIYM6v6VkgZy3oPhYF_8Drp6tlgi_IZHR4tn8UVT0dogwSkyKSlgk9myYms30F4YfIlJzZqeG9TDMbmx5XhmsmhO5pra3lWsNDQxQ5mA386stL0nK5M68JTfCOgukEGfiac6V4YmeCQwIJWZNRHcLql5pmFfAc-24sUkh8UKNprdEUNZoGjXZI1EhdBeDHHePlhr2k1TywvENSrVpVWvglGhv6qaDYv0Tf1xaYwnSAezzambyEP0RYj4dIdsirYJHNYwzwHDLvg2Lkmq02AxA1vn7FzS88cjwWDDyB6JBuY9X30s6b_xV4Sx7DrzgU470jreK6NDsQ9hXTXdIe7h3sjXarz_4XrulF8A |
linkProvider | Unpaywall |
linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlZ3db9MwEMAt6B7gBQbjo4whIyHeUto6dpzHamIaSJsqbZXGU3RNba1acaY1EYy_njs7ydoV2His4kuVy8V3Z59_x9gHJWITy1xGKQ6I4gG-Cw1JHIEFQO-RmNzjmo6O1eEk_nomz2442yvb94Ss_ERF8gl6UarBEj2daCHSh2xL0W5Sh21Njsejbw29Owl909BjEmLXMz4xORGYaql-ODT311uuOaXtGll63hZg3cKY_ikY3aypfFS5S7j-AYvFisM6eBpOgi8955DqVC56VTnt5b82KZD30cU2e1IHrnwULO0Ze2Dcc7Yzcpi0f7_mH7kvJfVr9DtsftQ03eXj0BN8yQvLx9SHiLYE5i76QudSCoxY_XzLPSPELfnccYxI-UlFAObiip8GctaC71NR8E-6frJaJviCTQ4-n-4fRnVPhyjHxKSMEisUzKapye1AY_ihcp3M7NTIfg7CxqYvtZEglII-AFgrAfChMYoczoZ-9eUl67jCmdeMp3RHJSAlBj5IqbVM7UxJTCAxazK6y0TzUrO8Bp5T341FhokPaTRrNJqRRrOg0S6LWqnLAPy4Y3yyYS9ZPQ8s75DUq1aVlX6JxoZ-KiT2L9H3jQVmOB3QHg84U1T4hwTr8RDJLnsVLLJ9jCGdQ5YDVEyyZqvtAEKNr19x83OPHI-VQE-guqzXWvW9tPPmfwV22WP8FYdivLesU15VZg_DvnL6rv7cfwOH2kR- |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Molecular+Profiles+of+Parvalbumin-Immunoreactive+Neurons+in+the+Superior+Temporal+Cortex+in+Schizophrenia&rft.jtitle=Journal+of+neurogenetics&rft.au=Pietersen%2C+Charmaine+Y.&rft.au=Mauney%2C+Sarah+A.&rft.au=Kim%2C+Susie+S.&rft.au=Passeri%2C+Eleonora&rft.date=2014-06-01&rft.issn=0167-7063&rft.eissn=1563-5260&rft.volume=28&rft.spage=70&rft.epage=85&rft_id=info:doi/10.3109%2F01677063.2013.878339&rft_id=info%3Apmid%2F24628518&rft.externalDocID=PMC4633016 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0167-7063&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0167-7063&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0167-7063&client=summon |